Callan Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $3.92M | Buy |
4,745
+645
| +16% | +$533K | 0.29% | 51 |
|
|
2024
Q4 | $3.17M | Sell |
4,100
-220
| -5% | -$170K | 0.23% | 61 |
|
|
2024
Q3 | $3.83M | Buy |
4,320
+377
| +10% | +$334K | 0.27% | 54 |
|
|
2024
Q2 | $3.57M | Buy |
3,943
+536
| +16% | +$485K | 0.29% | 54 |
|
|
2024
Q1 | $2.65M | Buy |
3,407
+579
| +20% | +$450K | 0.23% | 58 |
|
|
2023
Q4 | $1.65M | Buy |
2,828
+1,779
| +170% | +$1.04M | 0.16% | 71 |
|
|
2023
Q3 | $563K | Buy |
1,049
+247
| +31% | +$133K | 0.06% | 112 |
|
|
2023
Q2 | $376K | Buy |
802
+120
| +18% | +$56.3K | 0.04% | 127 |
|
|
2023
Q1 | $234K | Sell |
682
-130
| -16% | -$44.6K | 0.03% | 161 |
|
|
2022
Q4 | $297K | Buy |
+812
| New | +$297K | 0.04% | 145 |
|